CAI vs CTRA · rev $812.0M vs P/E 15, rev $5.46B
Caris Life Sciences, Inc. Common Stock (CAI) versus Coterra Energy Inc (CTRA) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
CAI currently screens at market cap $5.22B. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Not investment advice. Open the CAI and CTRA stock pages for the full models.
Not investment advice.